↓ Skip to main content

YIV-818-A: a novel therapeutic agent in prostate cancer management through androgen receptor downregulation, glucocorticoid receptor inhibition, epigenetic regulation, and enhancement of apalutamide…

Overview of attention for article published in Frontiers in Pharmacology, October 2023
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
4 Mendeley